Posted by Michael Wonder on 11 Jun 2021
Moderna files for emergency use authorisation for its COVID-19 vaccine in adolescents in the United States
10 June 2021 - Submission based on Phase 2/3 trial of mRNA-1273 in adolescents ages 12 to less than 18 in the U.S.
Moderna today announced that it has requested an emergency use authorisation for its COVID-19 vaccine in adolescents with the U.S. FDA.
